<DOC>
	<DOCNO>NCT00255671</DOCNO>
	<brief_summary>RATIONALE : Learning side effect stereotactic radiosurgery patient brain tumor brain disorder may help doctor plan treatment help patient live comfortably . PURPOSE : This clinical trial study acute side effect patient undergo stereotactic radiosurgery brain tumor brain disorder .</brief_summary>
	<brief_title>Acute Side Effects Patients Who Are Undergoing Stereotactic Radiosurgery Brain Tumors Other Brain Disorders</brief_title>
	<detailed_description>OBJECTIVES : - Determine incidence type acute complication patient undergo stereotactic radiosurgery brain tumor brain disorder . - Determine time frame development resolution complication patient . - Determine severity complication patient . OUTLINE : Patients undergo stereotactic radiosurgery . Patients also complete questionnaire side effect experience radiosurgery . The questionnaire complete baseline 1 week , 1 month , 2 month radiosurgery . PROJECTED ACCRUAL : A total 94 patient accrue study .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis brain tumor brain disorder , include , limited , 1 following : Primary brain tumor Brain metastasis Acoustic neuromas Pituitary adenomas Parkinson 's disease Cluster headaches Glomus jugulare Epilepsy Obsessive compulsive disorder Arteriovenous malformation Trigeminal neuralgia Eligible schedule undergo stereotactic radiosurgery PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No physical mental limitation would preclude study compliance PRIOR CONCURRENT THERAPY : Endocrine therapy Concurrent steroid allow Radiotherapy No prior stereotactic radiosurgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>radiation toxicity</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic meningioma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult melanocytic lesion</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult papillary meningioma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
	<keyword>adult grade I meningioma</keyword>
	<keyword>adult grade II meningioma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>ACTH-producing pituitary tumor</keyword>
	<keyword>growth hormone-producing pituitary tumor</keyword>
	<keyword>nonfunctioning pituitary tumor</keyword>
	<keyword>prolactin-producing pituitary tumor</keyword>
	<keyword>recurrent pituitary tumor</keyword>
	<keyword>TSH produce pituitary tumor</keyword>
</DOC>